Private Trust Co. NA Has $43,000 Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Private Trust Co. NA lifted its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 35.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,585 shares of the pharmacy operator’s stock after purchasing an additional 1,200 shares during the quarter. Private Trust Co. NA’s holdings in Walgreens Boots Alliance were worth $43,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Brooklyn Investment Group grew its holdings in shares of Walgreens Boots Alliance by 21.1% during the fourth quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock worth $44,000 after buying an additional 830 shares in the last quarter. First Financial Corp IN grew its holdings in shares of Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 885 shares in the last quarter. CWA Asset Management Group LLC grew its holdings in shares of Walgreens Boots Alliance by 9.2% during the fourth quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock worth $120,000 after buying an additional 1,084 shares in the last quarter. OLD Second National Bank of Aurora grew its holdings in shares of Walgreens Boots Alliance by 35.1% during the third quarter. OLD Second National Bank of Aurora now owns 4,562 shares of the pharmacy operator’s stock worth $41,000 after buying an additional 1,185 shares in the last quarter. Finally, Crestwood Advisors Group LLC grew its holdings in shares of Walgreens Boots Alliance by 6.3% during the fourth quarter. Crestwood Advisors Group LLC now owns 20,184 shares of the pharmacy operator’s stock worth $188,000 after buying an additional 1,199 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

WBA has been the subject of a number of research reports. Royal Bank of Canada increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 15th. Evercore ISI raised their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. Truist Financial decreased their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Bank of America raised their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Finally, Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating and decreased their price target for the company from $11.00 to $9.00 in a research note on Friday, February 28th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $11.54.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ WBA opened at $10.75 on Thursday. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $22.05. The stock has a 50 day moving average of $10.58 and a 200-day moving average of $9.72. The company has a market capitalization of $9.29 billion, a P/E ratio of -1.05, a P/E/G ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.66 EPS. As a group, equities research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.